» Articles » PMID: 11128810

Opposing Roles of Interferon-gamma on CD4+ T Cell-mediated Graft-versus-host Disease: Effects of Conditioning

Overview
Date 2000 Dec 29
PMID 11128810
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Although alloreactive T cells are required for the induction of graft-versus-host disease (GVHD), other factors can influence outcome in murine models of the disease. Lethal total body irradiation (TBI) conditioning regimens followed by reconstitution with allogeneic lymphohematopoietic cells results in the generation of donor anti-host cytotoxic T lymphocyte (CTL)-mediated solid organ (gut, liver, skin) destruction. In contrast, donor anti-host CTL-mediated hematopoietic failure is the primary cause of morbidity following sublethal TBI. To determine the role of interferon (IFN)-gamma in graft-versus-host reactions against hematopoietic and solid organ targets, we used IFN-gamma knockout mice as donors in both lethal TBI and bone marrow transplantation (BMT) rescue and sublethal TBI models. In this report, we show that CD4+ T cells from IFN-gamma knockout (KO) mice resulted in accelerated GVHD after lethal TBI/BMT using a single major histocompatibility class II mismatch model. In marked contrast, the use of these same IFN-gamma KO CD4+ donor cells in combination with sublethal TBI significantly ameliorated GVHD-associated mortality. In these recipients, severe anemia, bone marrow aplasia, and intestinal lesions were observed in the presence but not the absence of donor-derived IFN-gamma. Administration of anti-IFN-gamma antibodies to sublethally irradiated recipients of wild-type donor cells confirmed the role of IFN-gamma depletion in CD4+ T cell-mediated GVHD. In conclusion, the extent of conditioning markedly affects the role of IFN-gamma in GVHD lesions mediated by CD4+ T cells. In models using sublethal TBI, the absence of IFN-gamma is protective from GVHD, whereas in lethal TBI situations, the loss is deleterious.

Citing Articles

IFN-γ induces acute graft-versus-host disease by promoting HMGB1-mediated nuclear-to-cytoplasm translocation and autophagic degradation of p53.

Wang S, Cheng T, Chen X, Zeng C, Qin W, Xu Y Clin Sci (Lond). 2024; 138(20):1287-1304.

PMID: 39312196 PMC: 11479981. DOI: 10.1042/CS20241144.


T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?.

Campe J, Ullrich E Front Immunol. 2022; 12:806529.

PMID: 35069590 PMC: 8766661. DOI: 10.3389/fimmu.2021.806529.


Immune Suppression in Allogeneic Hematopoietic Stem Cell Transplantation.

Michniacki T, Choi S, Peltier D Handb Exp Pharmacol. 2021; 272:209-243.

PMID: 34628553 PMC: 9055779. DOI: 10.1007/164_2021_544.


Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signature.

Macedo R, Pasin C, Ganetsky A, Harle D, Wang X, Belay K Transplant Cell Ther. 2021; 28(1):18.e1-18.e10.

PMID: 34597852 PMC: 8792200. DOI: 10.1016/j.jtct.2021.09.017.


Antibiotic administration exacerbates acute graft vs. host disease-induced bone marrow and spleen damage in lymphopenic mice.

McDaniel Mims B, Enriquez J, Dos Santos A, Jones-Hall Y, Dowd S, Furr K PLoS One. 2021; 16(8):e0254845.

PMID: 34358240 PMC: 8346256. DOI: 10.1371/journal.pone.0254845.